The next infant formula staple? NZMP eyes milk fat globule membrane potential

636783908694345906baby infant formula.jpg

21 Nov 2018 --- As scientific understanding of infant development evolves, the industry is seeing growing opportunities for infant nutrition formulas that come as close to human breast milk as possible, and which benefit aspects such as brain and immune health. In this space, NZMP, Fonterra’s B2B ingredients business, is making strides in uncovering the potential of milk fat globule membrane (MFGM).

Although breastfeeding is recognized as the best method of ensuring that infants get the best nutrition possible, for those infants unable to consume mother’s milk, infant formula is the only suitable alternative.

NZMP’s Dr. Sophie Gallier, a senior research scientist in nutrition, last week gave a keynote presentation at the International Symposium on Milk Genomics and Human Health in Sacramento on the science of MFGM, which is also covered in a white paper.

Gallier’s presentation covered the scientific community’s current understanding of the MFGM composition, structure and role in infant nutrition. She discussed the most recent research results, as well as the potential future developments needed to manufacture infant formula to more closely match the nutritional benefits of human milk.

Click to Enlarge
Dr. Sophie Gallier, Senior Research Scientist in Nutrition at NZMP.

“NZMP has two commercial ingredients (SureStart MFGM Lipid 100 and 70) that contain MFGM. The development of these two ingredients was based on the realization that MFGM lipids in human milk are crucial to brain development. MFGM lipids are not present in infant formula due to the common use of vegetable oils as a source of fat, instead of milk fat. This points  to the increasing need for adding those specific lipids back into infant formula,” Gallier tells NutritionInsight. 

“These specific lipids are complex milk lipids found in the milk fat globule membrane, which is the trilayer of phospholipids and other lipids and membrane proteins. They stabilize the milk fat globules in human milk and milk from other mammalian species.”

Crucial to the success of these ingredients in infant nutrition, Gallier says, is proof that they play a role in infant nutrition and brain development early in life.

“There is a recognition that the first few years of life are very critical for long-term health. The brain develops rapidly during pregnancy but also in the first few years of life, making it important to give the right nutrition during these periods,” she says. “Brain development is one of the key aspects that parents are interested in. They are also interested in protection against infections early in life and the MFGM also plays a role in that.”  

Click to Enlarge
SureStart MFGM Lipid 100 and 70 are two dairy ingredients rich in milk fat globule
membrane for pediatric applications to support healthy brain development.

Composition presents challenges
“One of the key challenges is that a lot of the development of pediatric ingredients and the regulatory requirements for infant formula products are focused on the composition, aiming to deliver infant formula with a composition closer to that of human milk. But there is increasing recognition that the structure of food plays a key role in digestion and bioavailability of nutrients,” she notes. 

“If you look at human milk lipids, they are present as globules stabilized by a particular membrane, the MFGM. The way formula manufacturers make an infant formula results in a fat structure that is very different. So it is a lipid droplet that is much smaller than the milk fat globule, but also the membrane interface of the infant formula lipid droplets is very different to that of the milk fat globule membrane. The surface comprises mostly proteins instead of having this very complex trilayer of phospholipids with different specific membrane proteins and lipids such as cholesterol.”

“One of the main challenges from the food science point of view is going to be replicating the milk fat globule structure. The structure likely has an impact on the digestion kinetics and lipid metabolism. This contributes to the delivery of lipids at the right time in the body and right place in the gastrointestinal tract, where they may play a role on gut protection or maturation or be better absorbed.”

Although the company sees great potential for MFGM, Gallier points to the need to replicate clinical studies to demonstrate the role of MFGM for brain development. This is because clinical trial evidence so far has been based on trials with different ingredients, MFGM doses, clinical trial designs and developmental assessments.

Moreover, strong scientific evidence is needed for all infant nutrition ingredients to convey that they can support the development of infants. Regulatory pathways can also prove tricky, with tighter requirements for ingredients for pediatric applications. 

“Depending on the jurisdiction, an ingredient might have different names. We need to have a clear route for regulatory approvals and marketing it. And usually, regulatory and market access involves showing that the ingredient is safe, suitable and efficacious,” she notes. “To facilitate this, NZMP has a very strong research program to provide the scientific evidence needed to support the sale of our ingredients for inclusion in infant formula.”

Research and development is ongoing, but Gallier points to the huge potential for MFGM in infant nutrition, noting it could become as popular as DHA.

“The main lipid that has gotten quite a lot of attention the last 30 years and that is present in human milk is DHA. Its addition to infant formula is becoming mainstream and compulsory in some jurisdictions. It is quite well known that DHA plays a role for brain function, but we currently realize that there is more than DHA for brain development in early life. What we will probably see in the next few years is that the MFGM will become the new DHA. It will become something that almost all, if not all, infant formula manufacturers will be adding to infant formula,” she concludes.

By Lucy Gunn
 

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Under plant-based pressure: “Plenty of room on the shelf,” say dairy ingredient suppliers

06 Dec 2018 --- Interest in plant-based nutrition is showing no signs of slowing down, with The Plant Kingdom being one of Innova Market Insights’ Top Trends for 2019. Plant-based options are flourishing in a range of categories, with dairy alternatives, for example, on the rise. But what will this plant-centered NPD boom spell for dairy suppliers, as consumer interest turns toward the ever-growing range of non-dairy options? At HiE 2018 in Frankfurt, Germany, NutritionInsight spoke with a number of dairy ingredients suppliers to hear their views on plant-based NPD growth and how it will impact the dairy ingredients sector.

Health & Nutrition News

Untapped dairy opportunity? NZMP eyes protein and nutritional benefits in Southeast Asia  

16 Oct 2018 --- NZMP, Fonterra’s global B2B ingredients brand, is seeing increasing interest in dairy ingredients in South and Southeast Asia owing to their applicability in formats as wide-ranging as medical nutrition, protein fortification and sports nutrition. As consumer knowledge grows, so do the opportunities for new product development, Fonterra’s General Manager of NZMP Ingredients for South & East Asia, Hamish Gowans, tells NutritionInsight.

Health & Nutrition News

Future of personalized nutrition lies in investment and tech collaborations: Newtrition X. summit 2018

27 Sep 2018 --- The “nutrition revolution” has begun, according to the speakers of the Newtrition X. summit, which focused on presenting personalized nutrition from an interdisciplinary perspective. NutritionInsight spoke with two of the key speakers following the event, Professor Christian Sina from the University of Luebeck and Jo Goossens of nutrition consultancy company shiftN, to present their views on the future of personalization. Both experts agree that the success of personalized nutrition lies in a multitude of actors from different industries working in tandem, with Dr. Sina emphasizing scientific research and Goossens emphasizing technology companies.

Health & Nutrition News

Clinical nutrition: Trending platforms for optimal recovery

05 Sep 2018 --- The medical nutrition space, which includes oral nutritional supplements (ONS) and enteral nutrition (tube feeding via the nose or gastrointestinal tract), is enjoying increased growth. Oral nutritional supplements, in particular, are experiencing a boost as consumers and healthcare providers increasingly prioritize health & wellness, focusing more on aging well and disease prevention. Moreover, ongoing research into the benefits of nutrition on the healing process, as well as a growing demand for products that have a chance of encouraging patient compliance, are providing ample opportunities for ongoing R&D. 

Health & Nutrition News

NZMP: BifidoB infant nutrition ingredient found to help protect against infection

11 Jul 2018 --- A study has found that NZMP SureStart BifidoB 019 supplemented formula can help reduce physician-confirmed infections as well as the need for prescribed antibiotic or antiviral medication in infants aged 6-15 months consuming the formula relative to an unsupplemented control group.

More Articles
URL : http://www.nutritioninsight.com:80/news/the-next-infant-formula-staple-nzmp-eyes-milk-fat-globule-membrane-potential.html